Cipla Ltd.

1480.35 +3.35 ▲0.2%

29 February 2024, 04:12:09 PM
Volume: 4,923,680

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cipla.com
Market Cap 119,792.84 Cr.
Enterprise Value(EV) 119,286.72 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 45.93 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 32.31 Trailing Twelve Months Ending 2023-12
Industry PE 41.63 Trailing Twelve Months Ending 2023-12
Book Value / Share 320.72 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.63 Calculated using Price: 1,483.75
Dividend Yield 0.57 Period Ending 2023-03
No. of Shares Subscribed 80.74 Cr. 807,365,404 Shares
FaceValue 2
About Cipla Ltd.
The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The company has its wide network of manufacturing, trading and other incidental operations in India and International markets.

Cipla Ltd. Delivery

Delivered Qty
Traded Qty

Cipla Ltd. Performance

1 Day
+0.23%
1 Week
+2.28%
1 Month
+8.08%
3 Month
+24.16%
6 Month
+20.46%
1 Year
+63.32%
2 Year
+60.03%
5 Year
+166.95%
10 Year
+285.21%

Cipla Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 12.1 12.61 8.72 10.65 10.37 10.09 14.13 13.1 12.85
Return on Capital Employed (%) 15.33 13.24 8.28 10.2 11.94 12.53 17.85 17.24 18.19
Return on Assets (%) 7.85 7.28 4.97 6.52 6.5 6.56 9.95 9.94 10.19

Cipla Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 10,801 11,516 12,544 14,229 15,012 15,763 18,327 20,842 23,408 24,825
Non Curr. Liab. 2,418 1,407 4,513 4,259 4,646 2,972 1,660 622 184 146
Curr. Liab. 3,881 7,776 3,374 3,832 3,772 4,393 4,591 4,913 5,033 5,648
Minority Int. 180 350 438 352 332 294 259 276 306 270
Equity & Liab. 17,281 21,049 20,869 22,673 23,762 23,423 24,837 26,652 29,007 30,889
Non Curr. Assets 9,689 12,208 12,064 11,859 11,335 11,717 11,628 11,925 11,732 11,882
Curr. Assets 7,591 8,841 8,736 10,814 12,425 11,704 13,181 14,711 16,805 19,007
Misc. Exp. not W/O
Total Assets 17,281 21,049 20,869 22,673 23,762 23,423 24,837 26,652 29,007 30,889

Cipla Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 11,345 13,595 14,394 15,156 16,362 17,132 19,160 21,763 22,753 25,350
Other Income 166 208 229 358 477 369 270 322 512 632
Total Income 11,511 13,803 14,623 15,513 16,839 17,501 19,429 22,085 23,265 25,982
Total Expenditure -9,184 -11,115 -11,919 -12,329 -13,265 -13,951 -14,911 -17,251 -17,763 -19,201
PBIDT 2,327 2,688 2,704 3,184 3,574 3,550 4,518 4,834 5,502 6,781
Interest -168 -207 -159 -114 -168 -197 -161 -106 -110 -107
Depreciation -505 -754 -1,323 -1,323 -1,326 -1,175 -1,068 -1,052 -1,172 -1,109
Taxation -400 -332 -180 -250 -570 -631 -889 -934 -1,203 -1,444
Exceptional Items -78 -182 -182 -377
PAT 1,254 1,395 1,042 1,419 1,510 1,547 2,401 2,559 2,835 3,744
Minority Interest -48 -23 -29 -6 35 47 16 -30 -31 -35
Share Associate -25 -12 -7 -3 -17 -47 -13 -13 -3 -1
Other Related Items
Consolidated Net Profit 1,181 1,360 1,006 1,411 1,528 1,547 2,405 2,517 2,802 3,708
Adjusted EPS 15 17 13 18 19 19 30 31 35 46

Cipla Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1,563 1,173 1,741 2,382 1,463 1,691 3,068 3,755 3,326 3,238
Cash Fr. Inv. -1,250 -941 -4,523 -1,310 -854 -1,669 104 -2,387 -1,872 -2,389
Cash Fr. Finan. -266 165 3,104 -1,326 -385 -349 -2,949 -1,240 -1,600 -958
Net Change 48 397 322 -254 223 -326 224 129 -146 -109
Cash & Cash Eqvt 176 564 858 610 853 508 742 790 658 561

Cipla Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 36.11 33.63 33.61 33.61 33.61 33.55 33.47 33.47 33.47
Public 63.89 66.37 66.39 66.39 66.39 66.45 66.53 66.53 66.53
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Cipla Ltd. Announcements

Fri, 16 Feb 2024
Alteration Of Capital and Fund Raising-XBRL
Cipla Limited has informed the Exchange regarding Allotment of Securities
Fri, 16 Feb 2024
ESOP/ESOS/ESPS
Cipla Limited has informed the Exchange regarding Allotment of 5863 Shares.
Tue, 13 Feb 2024
Loss/Duplicate-Share Certificate-XBRL
Cipla Limited has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation

Cipla Ltd. Technical Scans

Thu, 29 Feb 2024
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Cipla Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 378,183.18 1,577.95 +0.3%
Dr. Reddy's Laboratories Ltd. 107,100.71 6,424.25 -0.1%
Zydus Lifesciences Ltd. 95,405.30 941.90 +1.0%
Divi's Laboratories Ltd. 92,624.64 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. 90,256.63 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. 87,793.47 6,105.90 -3.9%
Mankind Pharma Ltd. 85,543.66 2,135.45 +4.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.46 1,577.95 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.49 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 66.98 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.41 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 111.23 6,105.90 -3.9%
Mankind Pharma Ltd. Consolidated 2023-12 49.53 2,135.45 +4.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.06 1,577.95 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.11 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.62 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.00 6,105.90 -3.9%
Mankind Pharma Ltd. Consolidated 2023-12 9.63 2,135.45 +4.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,135.45 +4.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,135.45 +4.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,135.45 +4.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,135.45 +4.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,135.45 +4.0%

Cipla Ltd. FAQ's

What is Cipla share price?

Can I buy Cipla shares now?

What is the Dividend Yield of Cipla?

What is the Market Cap of Cipla?

What are the key metrics to analyse Cipla?

What is the 52 Week High and Low of Cipla?

What is the trend of Cipla share price?